Quidel received BARDA funding to develop point-of-care diagnostic assay that includes COVID-19
On Jun. 11, 2020, Quidel announced it had received funding from the Biomedical Advanced Research and Development Authority…
-
-
Innovation Pharma collaborated with regional biocontainment lab on grant application to research Brilacidin as pan-Coronavirus therapeutic
On Jun. 11, 2020, Innovation Pharma and researchers at a U.S. Regional Biocontainment Laboratory (RBL) announced they are…
-
Two science publications highlight potential of REGN-COV2 anti-viral antibody cocktail to protect against SARS-CoV-2 escape mutants
On Jun. 11, 2020, Regeneron announced that Science had accepted for publication two papers describing the creation of…
-
The FDA authorized first next generation sequence test for diagnosing COVID-19
On Jun. 10, 2020, the the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA)…
-
COVID-19 mouse model announced to speed search for drugs, vaccines
On Jun. 10, 2020, researchers at Washington University School of Medicine in St. Louis reported they have developed…
-
Johnson & Johnson announced acceleration of its COVID-19 vaccine candidate with phase 1/2a clinical trial
On Jun. 10, 2020, Johnson & Johnson announced that through its Janssen Pharmaceutical subsidiary it has accelerated the…
-
OraSure received BARDA funding for Coronavirus Antibody ELISA using oral fluid samples
On Jun. 10, 2020, OraSure Technologies announced it had been awarded a $629,217 contract from the Biomedical Advanced…
-
Catalent partnered with Spicona to develop COVID-19 vaccine candidate using GPEx cell line development platform
On Jun. 10, 2020, Catalent announced that it had signed an agreement with Spicona to develop a virus-like…
-
RedHill Biopharma submited COVID-19 clinical trial application for phase 2/3 study with Opaganib in Russia
On Jun. 10, 2020, RedHill Biopharma announced it had submitted a Clinical Trial Application (CTA) with the Ministry…
-
BioCryst’s galidesivir stops Zika viral replication in primate model
On Jun. 10, 2020, BioCryst Pharmaceuticals announced new data published in Science Translational Medicine that show, in a…
-
Immunic announced FDA allowance of its phase 2, CALVID-1 clinical trial of IMU-838 in COVID-19
On Jun. 9, 2020, Immunic announced receipt of regulatory allowance from the FDA to initiate its phase 2,…
-
Illumina received first FDA Emergency Use Authorization for sequencing-based COVID-19 diagnostic test
On Jun. 9, 2020, Illumina announced the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization…
-
Quidel’s received amended Emergency Authorization for rapid antigen COVID-19 diagnostic assay
On Jun. 9, 2020, Quidel announced that is had received an amended Emergency Use Authorization (EUA) from the…
-
Up to 45 percent of SARS-CoV-2 infections may be asymptomatic, new analysis found
On Jun. 9, 2020, researchers from Scripps report that an extraordinary percentage of people infected by the virus…
-
OpGen released preliminary data demonstrating Unyvero HPN panel for pneumonia identified life-threatening bacterial co-infections in COVID-19 patients
On Jun. 9, 2020, OpGen announced preliminary data from an investigator initiated collaboration with Karolinska Institutet, Stockholm, Sweden,…
-
Emergency COVID-19 measures prevented more than 500 million infections
On Jun. 8, 2020, emergency health measures implemented in six major countries have ‘significantly and substantially slowed’ the…
-
Lilly announced start of phase 1 study for its second potential COVID-19 antibody treatment
On Jun. 8, 2020, Eli Lilly announced its partner Junshi Biosciences had dosed the first healthy volunteer in…
-
OraSure’s Oragene-Dx included in EUA allowing at-home saliva collection for use with Phosphorus SARS-CoV-2 test
On Jun. 8, 2020, OraSure Technologies announced that Phosphorus Diagnostics, a leader in diagnostic and bioinformatic solutions for…
-
The US Department of Defense established collaborative virus genetic sequencing capability for COVID-19
On Jun. 6, 2020, to jumpstart the Department of Defense’s (DoD) SARS-CoV-2 sequencing efforts, Armed Forces Health Surveillance…
-
Unique biorepository stores samples from Alberta COVID-19 patients for future research
On Jun. 5, 2020, the Alberta Precision Laboratories (APL) COVID-19 Biorepository was announced to ensure researchers have the…
-
Study identified potential approach to treat severe respiratory distress in patients with COVID-19
On Jun. 5, 2020, early data from a clinical study suggested that blocking the Bruton tyrosine kinase (BTK)…
-
Calquence showed promising clinical improvement in majority of 19 hospitalised COVID-19 patients
On Jun. 5, 2020, results published in Science Immunology showed that Calquence (acalabrutinib), a Bruton’s tyrosine kinase (BTK)…
-
University of Queensland, CEPI and CSL partnered to advance development of COVID-19 vaccine candidate
On Jun. 5, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, CSL and The University of Queensland (UQ)…
-
Sorrento announced COVIDTRAP(STI-4398) demonstrated in preclinical studies its ability to completely inhibit SARS-CoV-2 viral infection In vitro
On Jun. 5, 2020, Sorrento announced it had completed a preclinical batch of the STI-4398 (COVIDTRAP) protein and…
-
iBio announced second COVID-19 vaccine program
On Jun. 4, 2020, iBio announced initiation of preclinical immunization studies for its second COVID-19 vaccine platform. The…
-
Virginia Tech researchers established a reverse genetics system to facilitate COVID-19 research
On Jun. 4, 2020, with funding from the Fralin Life Sciences Institute at Virginia Tech, researchers James Weger-Lucarelli…
-
AstraZeneca announced next steps towards broad and equitable access to Oxford Universitys COVID-19 vaccine
On Jun. 4, 2020, AstraZeneca announced the next steps in its commitment to broad and equitable global access…
-
Introduction and spread of SARS-CoV-2 in the greater Boston area
On Jun. 4, 2020, data from the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the…
-
Novavax awarded Department of Defense contract for COVID-19 vaccine
On Jun. 4, 2020, Novavax announced that the company had been awarded a contract by the U.S. Department…
-
CEPI granted $141 million to consortium of Bharat Biotech and IVI to advance development of Chikungunya vaccine in collaboration with Ind-CEPI
On Jun. 3, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, in collaboration with Ind-CEPI, announced a new…
